These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Decreased plasma endothelin-1 levels in children with sickle cell disease treated with hydroxyurea.
    Author: Lapouméroulie C, Benkerrou M, Odièvre MH, Ducrocq R, Brun M, Elion J.
    Journal: Haematologica; 2005 Mar; 90(3):401-3. PubMed ID: 15749673.
    Abstract:
    Plasma endothelin-1 (ET-1) is elevated in patients with sickle cell disease (SCD). Hydroxyurea (HU) is the only drug with demonstrated clinical efficacy in SCD. Here we show that treatment with HU results in a decreased concentration of circulating ET-1 which is not correlated with the HU-induced increase in HbF level. Blunting of the ET-1 vasoconstrictive stimulus could contribute to the beneficial effects of HU.
    [Abstract] [Full Text] [Related] [New Search]